Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

News Conference News PCR London Valves 2022

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

Shelley Wood

December 01, 2022

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

News Conference News CRT 2018

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Shelley Wood

March 07, 2018

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Industry News

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

June 08, 2017

News Industry News

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

December 01, 2016

News Daily News

TAVR 术后中度至重度二尖瓣关闭不全提示死亡风险上升

Todd Neale

June 18, 2015

News Daily News

Moderate-to-Severe Mitral Regurgitation Signals Elevated Mortality Risk After TAVR

Todd Neale

June 18, 2015

Advertisement

What’s Going to Be Hot at TCT 2025

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

TAVR 术后中度至重度二尖瓣关闭不全提示死亡风险上升

Moderate-to-Severe Mitral Regurgitation Signals Elevated Mortality Risk After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content